Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Decoding FDA drug approvals through clear clinical trial insights
Deep Dive in Clinical Trials
Clinical Drug Intelligence
Evidence from
trials to practice
Built by clinicians. Grounded in FDA data.
TrialistMD delivers structured, source-verified drug intelligence — from pivotal Phase 3 trial efficacy to real-world evidence — giving dermatologists and clinical pharmacologists the data they need, precisely formatted.
Dermatology drug approvals
IL inhibitors, JAK inhibitors, biologics & beyond
Phase 3 clinical trial analysis
Endpoints, baseline characteristics, efficacy & safety
Real-world evidence studies
Effectiveness, adherence & comparative outcomes
Dermatology drug approvals
IL inhibitors, JAK inhibitors, biologics & beyond — structured 7-tab profiles covering Overview, Baseline Characteristics, Efficacy, Safety, PK, Dosing, and Regulatory History.
Phase 3 clinical trial analysis
Source-verified extraction from FDA medical reviews and primary publications — endpoints, responder analyses, NNT, safety profiles, and subgroup data.
Real-world evidence studies
Post-marketing effectiveness, drug survival analyses, treatment persistence, and comparative effectiveness from registries and observational cohort studies.
In development — Phase 3 trial comparison tables and real-world evidence modules are currently being built.